Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Glucose transport in the heart.
Authors
Abel ED.
Submitted By
E. Dale Abel on 3/12/2004
Status
Published
Journal
Frontiers in bioscience
Year
2004
Date Published
6/1/2004
Volume : Pages
9 : 201 - 215
PubMed Reference
14766360
Abstract
The heart is a unique organ in many ways. It consists of specialized muscle
cells (cardiomyocytes), which are adapted to contract constantly in a
coordinated fashion. This is vital to the survival of the organism given the
central role of the heart in the maintenance of the cardiovascular system that
delivers oxygen, metabolic substrates and hormones to the rest of the body. In
order for the heart to maintain its function it must receive a constant supply
of metabolic substrates, to generate ATP to maintain contractile function,
without fatigue. Thus the heart is capable of utilizing a variety of metabolic
substrates and is able to rapidly adapt its substrate utilization in the face of
changes in substrate supply. The major metabolic substrate for the heart is
fatty acids. However, up to 30% of myocardial ATP is generated by glucose and
lactate, with smaller contributions from ketones and amino acids. Although
glucose is not the major metabolic substrate in the heart at rest, there are
many circumstances in which it assumes greater importance such as during
ischemia, increased workload and pressure overload hypertrophy. Like all other
cells, glucose is transported into cardiac myocytes by members of the family of
facilitative glucose transporters (GLUTs). In this regard, cardiomyocytes bear
many similarities to skeletal muscle, but there are also important differences.
For example, the most abundant glucose transporter in the heart is the GLUT4
transporter, in which translocation to the plasma membrane represents an
important mechanism by which the net flux of glucose into the cell is regulated.
Because cardiomyocytes are constantly contracting it is likely that contraction
mediated GLUT4 translocation represents an important mechanism that governs the
entry of glucose into the heart. While this is also true in skeletal muscle,
because many muscles are often at rest, insulin mediated GLUT4 translocation
represents a quantitatively more important mechanism regulating skeletal muscle
glucose uptake than is the case in the heart. In contrast to skeletal muscle,
where most GLUT1 is in perineural sheaths (1), in the heart there is significant
expression of GLUT1 (2), which under certain circumstances is responsible for a
significant component of basal cardiac glucose uptake. This review will
summarize the current state of knowledge regarding the regulation of glucose
transporter expression, and the regulation of glucose transport into myocardial
cells.
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Genes
Symbol
Description
Slc1a3
solute carrier family 1, member 3
Slc2a1
solute carrier family 2 (facilitated glucose transporter), member 1
Slc2a4
solute carrier family 2 (facilitated glucose transporter), member 4
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!